Karvy initiates coverage of Natco Pharma with a Buy Rating. Generic Copaxone is still a big opportunity despite US Supreme Court ruling. Natco to launch generic Sovaldi, another blockbuster drug for treatment of Hepatitis C, in India in 1QFY16. Tamiflu lawsuit currently ongoing, Natco is expected to prevail in the case allowing it to win 180-day exclusivity.